TY  - GEN
AU  - Ng,Khai P
AU  - Jain,Poorva
AU  - Heer,Gurdip
AU  - Redman,Val
AU  - Chagoury,Odette L
AU  - Dowswell,George
AU  - Greenfield,Sheila
AU  - Freemantle,Nick
AU  - Townend,Jonathan N
AU  - Gill,Paramjit S
AU  - McManus,Richard J
AU  - Ferro,Charles J
TI  - Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial
SN  - 1745-6215
PY  - 2015///0219
KW  - Attitude of Health Personnel
KW  - Biomarkers
KW  - blood
KW  - Cardiovascular Diseases
KW  - diagnosis
KW  - Clinical Protocols
KW  - Double-Blind Method
KW  - Early Diagnosis
KW  - England
KW  - General Practitioners
KW  - psychology
KW  - Health Knowledge, Attitudes, Practice
KW  - Humans
KW  - Hyperkalemia
KW  - Kidney Failure, Chronic
KW  - complications
KW  - Mineralocorticoid Receptor Antagonists
KW  - adverse effects
KW  - Pilot Projects
KW  - Potassium
KW  - Predictive Value of Tests
KW  - Primary Health Care
KW  - Prospective Studies
KW  - Pulse Wave Analysis
KW  - Qualitative Research
KW  - Research Design
KW  - Spironolactone
KW  - Surveys and Questionnaires
KW  - Time Factors
KW  - Treatment Outcome
KW  - Vascular Stiffness
KW  - drug effects
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1745-6215-15-158
ER  -